132 related articles for article (PubMed ID: 17630567)
1. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
Patel D; Thorne C; Newell ML
AIDS; 2007 Jul; 21(12):1656-7; author reply1657-8. PubMed ID: 17630567
[No Abstract] [Full Text] [Related]
2. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
[No Abstract] [Full Text] [Related]
3. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.
Kourtis AP; Schmid CH; Jamieson DJ; Lau J
AIDS; 2007 Mar; 21(5):607-15. PubMed ID: 17314523
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?
Mofenson LM
J Infect Dis; 2016 Apr; 213(7):1051-4. PubMed ID: 26265779
[No Abstract] [Full Text] [Related]
5. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
Martin F; Taylor GP
J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
[TBL] [Abstract][Full Text] [Related]
6. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
Short CE; Douglas M; Smith JH; Taylor GP
HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
Rudin C; Spaenhauer A; Keiser O; Rickenbach M; Kind C; Aebi-Popp K; Brinkhof MW; ;
HIV Med; 2011 Apr; 12(4):228-35. PubMed ID: 20726902
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.
Machado ES; Hofer CB; Costa TT; Nogueira SA; Oliveira RH; Abreu TF; Evangelista LA; Farias IF; Mercadante RT; Garcia MF; Neves RC; Costa VM; Lambert JS
Sex Transm Infect; 2009 Apr; 85(2):82-7. PubMed ID: 18987014
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
Li N; Sando MM; Spiegelman D; Hertzmark E; Liu E; Sando D; Machumi L; Chalamilla G; Fawzi W
J Infect Dis; 2016 Apr; 213(7):1057-64. PubMed ID: 26265780
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.
Powis KM; Kitch D; Ogwu A; Hughes MD; Lockman S; Leidner J; van Widenfelt E; Moffat C; Moyo S; Makhema J; Essex M; Shapiro RL
J Infect Dis; 2011 Aug; 204(4):506-14. PubMed ID: 21791651
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
Kourtis AP
J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
[No Abstract] [Full Text] [Related]
12. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
[TBL] [Abstract][Full Text] [Related]
13. Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis.
Tshivuila-Matala COO; Honeyman S; Nesbitt C; Kirtley S; Kennedy SH; Hemelaar J
AIDS; 2020 Sep; 34(11):1643-1656. PubMed ID: 32701581
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.
Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
AIDS; 2007 May; 21(8):1019-26. PubMed ID: 17457096
[TBL] [Abstract][Full Text] [Related]
15. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
Silf K; McMaster P; Hendriksz C
AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
[No Abstract] [Full Text] [Related]
16. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
[TBL] [Abstract][Full Text] [Related]
17. Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study.
Martin F; Taylor GP
J Infect Dis; 2007 Aug; 196(4):558-61. PubMed ID: 17624841
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
19. Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis, and Adverse Perinatal Outcomes in HIV Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
Hernández S; Catalán-García M; Morén C; García-Otero L; López M; Guitart-Mampel M; Milisenda J; Coll O; Cardellach F; Gratacós E; Miró Ò; Garrabou G
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):e113-e119. PubMed ID: 28234688
[TBL] [Abstract][Full Text] [Related]
20. Elevated Levels of Estradiol in Human Immunodeficiency Virus-Infected Pregnant Women on Protease Inhibitor-Based Regimens.
Balogun KA; Guzman Lenis MS; Papp E; Loutfy M; Yudin MH; MacGillivray J; Walmsley SL; Silverman M; Serghides L
Clin Infect Dis; 2018 Jan; 66(3):420-427. PubMed ID: 29020282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
